AstraZeneca Hong Kong Ltd
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Disease and Respiratory. We are also selectively active in the areas of autoimmunity, neuroscience and infection.
AstraZeneca Hong Kong oversees both the Hong Kong and Macau markets and attaches a strong importance to them. Since its inception in 1990, AstraZeneca Hong Kong has delivered many life-changing medicines that have transformed the lives of patients and have revolutionized disease treatment in Hong Kong and Macau. Over the years, we have been continually expanding our business in order to meet the growing demand of the markets.
Carol Mui - General Manager
Hugo Tan - Medical Director
Reza Nobar – Director, Innovation & Business Excellence
Elise Ho - Business Unit Director
Antony Ng - Business Unit Director
Shirley Tong - Head of Human Resources
Susanna Tang - Country Finance Lead
Number of Staff